653 related articles for article (PubMed ID: 31256694)
1. Managing antibiotic resistance in nontuberculous mycobacterial pulmonary disease: challenges and new approaches.
Kwon YS; Daley CL; Koh WJ
Expert Rev Respir Med; 2019 Sep; 13(9):851-861. PubMed ID: 31256694
[No Abstract] [Full Text] [Related]
2. Antibiotic treatment for nontuberculous mycobacterial lung disease.
Kang YA; Koh WJ
Expert Rev Respir Med; 2016; 10(5):557-68. PubMed ID: 26967761
[TBL] [Abstract][Full Text] [Related]
3. Treatment of slowly growing mycobacteria.
Philley JV; Griffith DE
Clin Chest Med; 2015 Mar; 36(1):79-90. PubMed ID: 25676521
[TBL] [Abstract][Full Text] [Related]
4. Management of nontuberculous mycobacterial (NTM) lung disease.
Philley JV; Griffith DE
Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
[TBL] [Abstract][Full Text] [Related]
5. [Clinical characteristics and drug susceptibility test of nontuberculous mycobacterial lung disease].
Lou H; Sun Q; Gu J; Yang H; Hao XH; Xiao HP; Sha W
Zhonghua Jie He He Hu Xi Za Zhi; 2019 Dec; 42(12):901-906. PubMed ID: 31826533
[No Abstract] [Full Text] [Related]
6. The treatment of rapidly growing mycobacterial infections.
Kasperbauer SH; De Groote MA
Clin Chest Med; 2015 Mar; 36(1):67-78. PubMed ID: 25676520
[TBL] [Abstract][Full Text] [Related]
7. Nontuberculous mycobacteria infections in immunosuppressed hosts.
Henkle E; Winthrop KL
Clin Chest Med; 2015 Mar; 36(1):91-9. PubMed ID: 25676522
[TBL] [Abstract][Full Text] [Related]
8. Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.
van Ingen J; Boeree MJ; van Soolingen D; Mouton JW
Drug Resist Updat; 2012 Jun; 15(3):149-61. PubMed ID: 22525524
[TBL] [Abstract][Full Text] [Related]
9. Successful antibiotic treatment of pulmonary disease caused by Mycobacterium abscessus subsp. abscessus with C-to-T mutation at position 19 in erm(41) gene: case report.
Kim SY; Shin SJ; Jeong BH; Koh WJ
BMC Infect Dis; 2016 May; 16():207. PubMed ID: 27188784
[TBL] [Abstract][Full Text] [Related]
10.
Kim DH; Jhun BW; Moon SM; Kim SY; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182533
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases.
Huh HJ; Kim SY; Jhun BW; Shin SJ; Koh WJ
Infect Genet Evol; 2019 Aug; 72():169-182. PubMed ID: 30315892
[TBL] [Abstract][Full Text] [Related]
12. Medications and monitoring in nontuberculous mycobacteria infections.
Egelund EF; Fennelly KP; Peloquin CA
Clin Chest Med; 2015 Mar; 36(1):55-66. PubMed ID: 25676519
[TBL] [Abstract][Full Text] [Related]
13. A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.
Lyu J; Kim BJ; Kim BJ; Song JW; Choi CM; Oh YM; Lee SD; Kim WS; Kim DS; Shim TS
Respir Med; 2014 Nov; 108(11):1706-12. PubMed ID: 25245792
[TBL] [Abstract][Full Text] [Related]
14. Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720.
Winthrop KL; Flume P; Hamed KA
Expert Rev Anti Infect Ther; 2023; 21(11):1177-1187. PubMed ID: 37862563
[TBL] [Abstract][Full Text] [Related]
15. Implication of species change of Nontuberculous Mycobacteria during or after treatment.
Lee JS; Lee JH; Yoon SH; Kim TS; Seong MW; Han SK; Yim JJ
BMC Pulm Med; 2017 Dec; 17(1):213. PubMed ID: 29262802
[TBL] [Abstract][Full Text] [Related]
16. Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence.
van Ingen J; Ferro BE; Hoefsloot W; Boeree MJ; van Soolingen D
Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1065-77. PubMed ID: 24124798
[TBL] [Abstract][Full Text] [Related]
17. Identification of Non-Tuberculosis Mycobacteria by Line Probe Assay and Determination of Drug Resistance Patterns of Isolates in Iranian Patients.
Karami-Zarandi M; Bahador A; Gizaw Feysia S; Kardan-Yamchi J; Hasan-Nejad M; Mosavari N; Feizabadi MM
Arch Razi Inst; 2019 Dec; 74(4):375-384. PubMed ID: 31939254
[TBL] [Abstract][Full Text] [Related]
18. Population-based Incidence of Pulmonary Nontuberculous Mycobacterial Disease in Oregon 2007 to 2012.
Henkle E; Hedberg K; Schafer S; Novosad S; Winthrop KL
Ann Am Thorac Soc; 2015 May; 12(5):642-7. PubMed ID: 25692495
[TBL] [Abstract][Full Text] [Related]
19. Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.
Guglielmetti L; Mougari F; Lopes A; Raskine L; Cambau E
Future Microbiol; 2015; 10(9):1467-83. PubMed ID: 26344005
[TBL] [Abstract][Full Text] [Related]
20. Medications and Monitoring in Treatment of Nontuberculous Mycobacterial Pulmonary Disease.
Sawka A; Burke A
Clin Chest Med; 2023 Dec; 44(4):815-828. PubMed ID: 37890918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
